Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks

Purpose: Myelodysplastic syndromes (MDS) with deletion of chromosome 7q/7 [-7/(del)7q MDS] is associated with worse outcomes and needs novel insights into pathogenesis. Reduced expression of signaling protein dedicator of cytokinesis 4 (DOCK4) in patients with -7/(del)7q MDS leads to a block in hematopoietic stem cell (HSC) differentiation. Identification of targetable signaling networks downstream of DOCK4 will provide means to restore hematopoietic differentiation in MDS. Experimental Design: We utilized phosphoproteomics approaches to identify signaling proteins perturbed as a result of reduced expression of DOCK4 in human HSCs and tested their functional significance in primary model systems. Results: We demonstrate that reduced levels of DOCK4 lead to increased global tyrosine phosphorylation of proteins in primary human HSCs. LYN kinase and phosphatases INPP5D (SHIP1) and PTPN6 (SHP1) displayed greatest levels of tyrosine phosphorylation when DOCK4 expression levels were reduced using DOCK4-specific siRNA. Our data also found that increased phosphorylation of SHIP1 and SHP1 phosphatases were due to LYN kinase targeting these phosphatases as substrates. Increased migration and impediment of HSC differentiation were consequences of these signaling alterations. Pharmacologic inhibition of SHP1 reversed these functional aberrations in HSCs expressing low DOCK4 levels. In addition, differentiation block seen in DOCK4 haplo-insufficient [-7/(del)7q] MDS was rescued by inhibition of SHP1 phosphatase. Conclusions: LYN kinase and phosphatases SHP1 and SHIP1 are perturbed when DOCK4 expression levels are low. Inhibition of SHP1 promotes erythroid differentiation in healthy HSCs and in -7/(del)7q MDS samples with low DOCK4 expression. Inhibitors of LYN, SHP1 and SHIP1 also abrogated increased migratory properties in HSCs expressing reduced levels of DOCK4.

[1]  K. Pradhan,et al.  Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis. , 2019, Cancer discovery.

[2]  C. Zhang,et al.  SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-β signaling , 2018, The Journal of experimental medicine.

[3]  A. Holoubek,et al.  Adhesion structures in leukemia cells and their regulation by Src family kinases , 2018, Cell adhesion & migration.

[4]  D. Figarella-Branger,et al.  DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression , 2018, Oncogene.

[5]  E. Daugas,et al.  Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation , 2017, Nature Communications.

[6]  W. Vainchenker,et al.  Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis , 2017, The Journal of clinical investigation.

[7]  A. Verma,et al.  Stem and progenitor cell alterations in myelodysplastic syndromes. , 2017, Blood.

[8]  K. Sachs,et al.  Distinct signaling programs control human hematopoietic stem cell survival and proliferation. , 2017, Blood.

[9]  M. Cragg,et al.  FcγRIIB-Independent Mechanisms Controlling Membrane Localization of the Inhibitory Phosphatase SHIP in Human B Cells , 2016, The Journal of Immunology.

[10]  M. L. Le Beau,et al.  Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes , 2015, Proceedings of the National Academy of Sciences.

[11]  C. Esmon,et al.  PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells , 2015, Nature Medicine.

[12]  Pamela F. Jones,et al.  A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis , 2015, Nature Communications.

[13]  Ying Jin,et al.  TGF-β/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis , 2015, Genes & development.

[14]  H. Katoh,et al.  Dock4 forms a complex with SH3YL1 and regulates cancer cell migration. , 2014, Cellular signalling.

[15]  Amit Verma,et al.  Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis. , 2014, Cell reports.

[16]  E. Kjeldsen,et al.  DOCK4 deletion at 7q31.1 in a de novo acute myeloid leukemia with a normal karyotype , 2013, Cellular Oncology.

[17]  H. Yoshida,et al.  The Drosophila DOCK family protein sponge is involved in differentiation of R7 photoreceptor cells. , 2013, Experimental cell research.

[18]  A. Hummon,et al.  Combination of multistep IMAC enrichment with high-pH reverse phase separation for in-depth phosphoproteomic profiling. , 2013, Journal of proteome research.

[19]  N. Ip,et al.  The Atypical Guanine Nucleotide Exchange Factor Dock4 Regulates Neurite Differentiation through Modulation of Rac1 GTPase and Actin Dynamics* , 2013, The Journal of Biological Chemistry.

[20]  H. Katoh,et al.  Rac GEF Dock4 interacts with cortactin to regulate dendritic spine formation , 2013, Molecular biology of the cell.

[21]  J. Greally,et al.  High Resolution Methylome Analysis Reveals Widespread Functional Hypomethylation during Adult Human Erythropoiesis* , 2013, The Journal of Biological Chemistry.

[22]  R. Seethala,et al.  Lyn Kinase Mediates Cell Motility and Tumor Growth in EGFRvIII-Expressing Head and Neck Cancer , 2012, Clinical Cancer Research.

[23]  J. Lieberman,et al.  Bone Morphogenetic Protein 4 Promotes Vascular Smooth Muscle Contractility by Activating MicroRNA-21 (miR-21), which Down-regulates Expression of Family of Dedicator of Cytokinesis (DOCK) Proteins* , 2011, The Journal of Biological Chemistry.

[24]  A. Huttenlocher,et al.  Lyn is a redox sensor that mediates leukocyte wound attraction in vivo , 2011, Nature.

[25]  O. Abdel-Wahab,et al.  Aberrant Epigenetic and Genetic Marks Are Seen in Myelodysplastic Leukocytes and Reveal Dock4 as a Candidate Pathogenic Gene on Chromosome 7q* , 2011, The Journal of Biological Chemistry.

[26]  M. Bitzer,et al.  Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. , 2011, Cancer research.

[27]  F. Puppo,et al.  The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome. , 2010, Blood.

[28]  S. Fujimoto,et al.  Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism , 2010, The Journal of cell biology.

[29]  E. Borden,et al.  Novel SHP-1 Inhibitors Tyrosine Phosphatase Inhibitor-1 and Analogs with Preclinical Anti-Tumor Activities as Tolerated Oral Agents , 2010, The Journal of Immunology.

[30]  M. Bitzer,et al.  Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. , 2008, Blood.

[31]  L. Zon,et al.  Molecular association between β-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/β-catenin signaling , 2008, Oncogene.

[32]  M. Yoder,et al.  Deficiency of Src family kinases compromises the repopulating ability of hematopoietic stem cells. , 2008, Experimental hematology.

[33]  M. Bitzer,et al.  Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS. Commentary , 2008 .

[34]  M. Kruhlak,et al.  Rapid T cell receptor‐mediated SHP‐1 S591 phosphorylation regulates SHP‐1 cellular localization and phosphatase activity , 2007, Journal of leukocyte biology.

[35]  Christie M. Orschell,et al.  Src family kinase-mediated negative regulation of hematopoietic stem cell mobilization involves both intrinsic and microenvironmental factors. , 2007, Experimental hematology.

[36]  R. Z. Vêncio,et al.  Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer , 2007, Cancer Cell International.

[37]  H. Katoh,et al.  Dock4 is regulated by RhoG and promotes Rac-dependent cell migration. , 2006, Experimental cell research.

[38]  A. Gewirtz,et al.  Integrin inhibition through Lyn-dependent cross talk from CXCR4 chemokine receptors in normal human CD34+ marrow cells. , 2006, Blood.

[39]  D. Yan,et al.  An isoform of GTPase regulator DOCK4 localizes to the stereocilia in the inner ear and binds to harmonin (USH1C). , 2006, Journal of molecular biology.

[40]  C. Quilici,et al.  Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. , 2004, Blood.

[41]  G. Krystal,et al.  The Inositol 5′-Phosphatase SHIP-1 and the Src Kinase Lyn Negatively Regulate Macrophage Colony-stimulating Factor-induced Akt Activity* , 2003, Journal of Biological Chemistry.

[42]  D. Haber,et al.  DOCK4, a GTPase Activator, Is Disrupted during Tumorigenesis , 2003, Cell.

[43]  D. Metcalfe,et al.  Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells. , 2001, Blood.

[44]  Arun Sharma,et al.  Engagement of Gab1 and Gab2 in Erythropoietin Signaling* , 1999, The Journal of Biological Chemistry.

[45]  T. Yi,et al.  Defective expression of the SHP-1 phosphatase in polycythemia vera. , 1999, Experimental hematology.

[46]  R. Jaster,et al.  SHP1 Protein Tyrosine Phosphatase Negatively Modulates Erythroid Differentiation and Suppression of Apoptosis in J2E Erythroleukemic Cells , 1999, Biological chemistry.

[47]  D. Wojchowski,et al.  Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells. , 1997, Blood.

[48]  A. Wickrema,et al.  Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. , 1992, Blood.